Quantum and Artificial Intelligence in Drugs and Pharmaceutics
BioChem · 14.01.2026 · 6 (1) · 2
DOI: 10.3390/biochem6010002 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioChem, online erschienen am 14.01.2026. Verfasst von Bruno F. E. Matarèse. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 426 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The pharmaceutical industry faces a broken drug development pipeline, characterized by high costs, slow timelines and is prone to high failure rates. The convergence of Artificial Intelligence (AI) and quantum technologies is poised to fundamentally transform this landscape. AI excels in interpreting complex data, optimizing processes and designing drug candidates, while quantum systems enable unprecedented molecular simulation, ultra-sensitive sensing and precise physical control. This convergence establishes an integrated, self-learning ecosystem for the discovery, development, and delivery of therapeutics. This framework co-designs strategies from molecular targeting to formulation stability, compressing timelines and enhancing precision, which may enable safer, faster, and more adaptive medicines.
Zitieren
APA
Matarèse, B. F. E. (2026). Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem, 6(1), 2. https://doi.org/10.3390/biochem6010002
Vancouver
Matarèse BFE. Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem. 2026;6(1):2. doi:10.3390/biochem6010002
BibTeX
@article{Matarse2026,
author = {Matarèse, Bruno F. E.},
title = {Quantum and Artificial Intelligence in Drugs and Pharmaceutics},
journal = {BioChem},
year = {2026},
volume = {6},
number = {1},
pages = {2},
doi = {10.3390/biochem6010002}
}
EUVIMED